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In the age of the Internet, five years can
seem like an eternity. PLoS Medicine issued
its first call for papers five years ago and
the inaugural issue went live online five
years ago this October—for those of you
who are nostalgic, check out the original
call for papers [1]. Anniversaries often
prompt reflection, and over the past few
months we’ve taken a close look at our
original plans for PLoS Medicine, what’s
happened since the journal launched, and
most importantly how the journal should
evolve in the future. We now propose a
refocusing of the journal’s priorities that
will, we believe, align them more closely
with the world’s health priorities.
To recap, we had two main aims when
we launched PLoS Medicine. First, to
provide an open-access alternative to top-
tier subscription medical journals such as
the New England Journal of Medicine and the
Lancet, in the same way that PLoS Biology
was launched a year earlier to challenge
the dominance of general subscription
science journals such as Science and Nature.
There was a niche in the market that
desperately needed filling—a need to
prove that the new model of open-access
publishing was compatible with the high-
est standards of medical journal publish-
ing. In our inaugural editorial, ‘‘Prescrip-
tion for a Healthy Journal’’ [2], we
acknowledged that the Internet was not
only the technology driving PLoS Medicine’s
inception but also was central to its ethos
by enabling ‘‘the revolutionary idea of
anyone being able to read any article.’’
Second, we had a vision for a journal that
had a clear ‘‘priority of publishing papers
on diseases that take the greatest toll on
health globally.’’
Has PLoS Medicine measured up to these
aims and are these aims still valid? For the
first, in the five years since PLoS Medicine
launched, open-access publishing has ma-
tured from a seemingly unrealistic dream
into a mainstream concept. We would
argue that our presence has led other
medical journals to begin to consider
making some of their content free access
(i.e., articles are free to read, but published
under traditional restrictive copyright) or
truly open access (free to read and
published under a progressive copyright
license allowing reuse) [3]. By 2005, a
study published in BMJ [4] found that
much of the literature was already freely
available online. In 2008, John Willinsky
argued further that ‘‘about twenty percent
of the research literature published today
ends up open access’’ [5] (though this may
not be true open access). The Directory of
Open Access Journals (http://www.doaj.
org/) now contains 3,999 journals. When
we launched, few authors were convinced
of the merits of open-access or even free-
access publishing compared with tradi-
tional publishing, and they rarely made
publishing decisions based on access to
their work. Now, however, authors are
starting to make decisions about publica-
tion based on how accessible the work will
be, and funders, governments, and insti-
tutions are routinely mandating open, or
more frequently free, access to the re-
search they support (see Peter Suber’s blog
Open Access News for an archive of
relevant developments [http://www.earlham.
edu/,peters/fos/fosblog.html]).
In addition to advancing open access,
PLoS is building on the potential of the
Internet to enable and enrich human
interaction around scientific publications.
A first step in this direction is the
integration of all the PLoS journals on
one publishing platform—as of last month
PLoS Medicine is hosted on our in-house
open-access platform, Topaz, which opti-
mizes user interactions. We invite you to
explore all the functionalities of Topaz,
including the ability to comment on and
rate the articles that we publish.
Within such a framework of access and
technology, what should PLoS Medicine’s
role be in the future, as the leading, fully
open-access general medical journal? We
have never found it sufficient just to fulfil
our first aim as an open-access alternative
to the other top medical journals—we
have tried to distinguish PLoS Medicine
from other journals in more active ways.
One example: we stated at the outset that
‘‘we have decided not to be part of the
cycle of dependency that has formed
between journals and the pharmaceutical
industry’’ [2]. We have broken that
dependency by banning advertisements
for drugs or medical devices; in addition,
because our open-access license allows
anyone worldwide to make unlimited
copies of any paper, we cannot benefit
from an exclusive reprint trade to drug
companies (a clinical trial published in a
subscription-based journal can earn that
journal thousands if not hundreds of
thousands of dollars in reprint sales).
To return to our second stated aim at
the outset, we also intended that PLoS
Medicine should be distinguished from
other Western medical journals by its
content. We always aimed to publish
papers highlighting diseases that affect a
large portion of the world’s population: the
‘‘global burden of disease.’’ We remain
guided by the conviction that research
reports, especially those on work that most
affects human health globally, must be
available to all, and not restricted by
access fees and legal barriers to reuse.
We believe that the first five years of PLoS
Medicine have brought substantial progress
toward this goal, and we now want to
focus our efforts on accomplishing it.
Thus, from April 2009 we will take an
evidence-based approach to identifying
topics of global health priority, and will
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that advance human health in these areas.
We will be guided in our editorial
decision-making by sources providing
evidence on the specific diseases and risk
factors that cause the greatest burden
worldwide. Such lists are of course not
perfect, so we will not apply them rigidly,
but will instead use them as a guide in
prioritizing papers for publication (for
examples, see [6–8]). Within these priority
areas we will make decisions based on: (1)
whether papers are likely to directly and
substantially affect clinical practice or
public health policy, or (2) whether they
have profound implications for the direc-
tion of future, clinically relevant research.
However, papers that report, for example,
biochemical pathways or genetic associa-
tions without clear application to human
health, would not reflect the new priorities
of PLoS Medicine. We believe there are
other open-access alternatives for such
papers (including other PLoS journals [9]).
In taking such an approach we empha-
sise the need to look beyond just the
biological causes of disease. Despite the
stunning advances that have been made in
understanding disease pathophysiology,
improving diagnosis, and developing new
therapies, human health remains inextri-
cably intertwined with the environment—
in its widest sense—in which we live. The
conditions and risk factors that cause the
highest burden of disease clearly reflect
these interrelationships. For example, it
would be simplistic to look only for the
biological causes of the morbidity and
mortality caused by perinatal conditions,
diarrhoeal diseases, poor nutrition, or
smoking. As the world faces up to the
challenges of a changing climate, a
turbulent economic system, and continued
global conflict, we now wish to reinforce
the important place in health research of
work that encompasses the social, envi-
ronmental, and political determinants of
health, as well as the biological.
Some things will not change: for
example, we will continue to prioritize
papers that cover important topics in the
ethics and reporting of research. And, as
always, we will publish papers across the
methodological spectrum, from observa-
tional research to basic pathophysiology.
Further details of our editorial mission can
be found on our Web site [10]. We
welcome your feedback on this initiative.
To give you a sense of our new scope, take
a look at the papers we are publishing this
week [11–16].
We believe our new, evidence-based
approach will not only ensure that open-
access publishing reflects the health prior-
ities of the 21st century, but will also
reaffirm and revitalize the long tradition of
medical journals leading, rather than
following, the debate over research prior-
ities.
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